Loading clinical trials...
Loading clinical trials...
A Randomized, Subject and Evaluator Blinded, Split-face, Pivotal, Multi-injection Clinical Trial to Evaluate the Efficacy and Safety of DLMR01 in Crow's Feet.
Conditions
Interventions
DLMR01
Rejuran
Locations
1
South Korea
Chung-ang University Hospital
Seoul, Dongjak-gu, South Korea
Start Date
July 7, 2020
Primary Completion Date
October 15, 2021
Completion Date
May 4, 2023
Last Updated
April 19, 2024
NCT06402058
NCT03408236
NCT04081402
NCT02248844
NCT01797081
NCT02176356
Lead Sponsor
DEXLEVO
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions